Integra LifeSciences (IART) Competitors

Integra LifeSciences (NASDAQ:IART) and Teleflex (NYSE:TFX) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, valuation, community ranking, media sentiment, analyst recommendations, institutional ownership and risk.

Does the MarketBeat Community believe in IART or TFX?

Teleflex received 89 more outperform votes than Integra LifeSciences when rated by MarketBeat users. Likewise, 58.64% of users gave Teleflex an outperform vote while only 56.83% of users gave Integra LifeSciences an outperform vote.

Company	Underperform	Outperform
Integra LifeSciences	Outperform Votes 437 56.83%	Underperform Votes 332 43.17%
Teleflex	Outperform Votes 526 58.64%	Underperform Votes 371 41.36%

Does the media prefer IART or TFX?

In the previous week, Teleflex had 10 more articles in the media than Integra LifeSciences. MarketBeat recorded 16 mentions for Teleflex and 6 mentions for Integra LifeSciences. Teleflex's average media sentiment score of 0.81 beat Integra LifeSciences' score of 0.78 indicating that Teleflex is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integra LifeSciences	3 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Teleflex	11 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more volatility and risk, IART or TFX?

Integra LifeSciences has a beta of 1.23, indicating that its stock price is 23% more volatile than the S&P 500. Comparatively, Teleflex has a beta of 1.21, indicating that its stock price is 21% more volatile than the S&P 500.

Do analysts recommend IART or TFX?

Integra LifeSciences presently has a consensus price target of $23.00, indicating a potential upside of 2.72%. Teleflex has a consensus price target of $182.63, indicating a potential upside of 29.91%. Given Teleflex's stronger consensus rating and higher possible upside, analysts plainly believe Teleflex is more favorable than Integra LifeSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integra LifeSciences	3 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.75
Teleflex	1 Sell rating(s)	8 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.09

Is IART or TFX more profitable?

Teleflex has a net margin of 7.85% compared to Integra LifeSciences' net margin of -0.42%. Teleflex's return on equity of 14.19% beat Integra LifeSciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integra LifeSciences	-0.42%	12.35%	4.82%
Teleflex	7.85%	14.19%	8.53%

Which has better valuation & earnings, IART or TFX?

Teleflex has higher revenue and earnings than Integra LifeSciences. Integra LifeSciences is trading at a lower price-to-earnings ratio than Teleflex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integra LifeSciences	$1.61B	1.07	$67.74M	-$0.09	-248.78
Teleflex	$3.05B	2.14	$356.33M	$1.42	99.00

Do insiders and institutionals have more ownership in IART or TFX?

84.8% of Integra LifeSciences shares are held by institutional investors. Comparatively, 95.6% of Teleflex shares are held by institutional investors. 3.1% of Integra LifeSciences shares are held by insiders. Comparatively, 1.4% of Teleflex shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Teleflex beats Integra LifeSciences on 16 of the 18 factors compared between the two stocks.